Lead Optizmization of a 4-Aminopyridine Benzamide Scaffold to Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors
Journal Article
·
· J. Med. Chem. 56, 4521 (2013)
OSTI ID:1185153
Abstract Not Provided
- Research Organization:
- SLAC National Accelerator Laboratory (SLAC)
- Sponsoring Organization:
- US DOE Office of Science (DOE SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1185153
- Report Number(s):
- SLAC-REPRINT-2015-029
- Journal Information:
- J. Med. Chem. 56, 4521 (2013), Journal Name: J. Med. Chem. 56, 4521 (2013)
- Country of Publication:
- United States
- Language:
- English
Similar Records
Lead Identification of Novel and Selective TYK2 Inhibitors
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Journal Article
·
Thu Oct 02 00:00:00 EDT 2014
· Eur. J. Med. Chem. 67, 175 (2013)
·
OSTI ID:1185154
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
Journal Article
·
Wed Apr 22 00:00:00 EDT 2020
· Journal of Medicinal Chemistry
·
OSTI ID:1635032
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Journal Article
·
Fri Jun 01 00:00:00 EDT 2018
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1474162